Sun Pharma settles generic Protonix litigation for $550 million

13 Jun 2013 Evaluate

Sun Pharmaceutical Industries, along with its subsidiaries, has settled an ongoing litigation pending in the United States District Court, District of New Jersey (Court) regarding Sun Pharma subsidiary’s generic pantoprazole.

Under the terms of the litigation settlement between Sun Pharma and Wyeth, now a division of Pfizer Inc and Atlanta Pharma AG, now known as Takeda GmbH, the parties have dismissed all their claims. Sun Pharma will pay a lump-sum $550 million as a part of this settlement. It will continue to sell its generic pantoprazole in the U.S.

Sun Pharmaceuticals Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×